Medical News

RSS

Ageing reversed in mice: Study

A scientific team at Harvard-affiliated medical centers genetically manipulated mice to age faster. Then they used gene therapy to lengthen telomeres. Telomeres are compounds found at the ends of strands of DNA that are related to age. This lengthening of telomeres reversed age-related problems such as decreased brain function and infertility.

29 Nov 2010

Australia’s largest skin cancer study

More than 400,000 people will be diagnosed with some form of skin cancer this year and the most deadly form of the disease, melanoma, will claim more than a thousand lives in Australia say researchers. Queensland has the highest rate of skin cancer in the world with fair-skinned people being most affected with the strong subtropical sun.

29 Nov 2010

Sun protection education to begin early

In a bid to prevent skin cancer the June E. Nylon Cancer Center has received a grant from the Ronald McDonald House Charities in the amount of $1,590 to fund treatments for sun damage among for students in the Sioux City Community Schools and also provide sunscreens to them.

29 Nov 2010

Queenslanders fatter but live longer and smoke less: Health report

A new health report reveals that more than 60 per cent of Queensland adults are overweight or obese. The Health of Queenslanders report also reveals that Queenslanders are living longer and smoking less.

29 Nov 2010

Stressed out being social: Survey

In a new Australian survey researchers have found that social media is causing people to become increasingly anxious, as users feel pressured to be constantly connected.

29 Nov 2010

GlobalNet Services awarded $6.2M contract to support Agency Wide Business Objects Support project

GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.

29 Nov 2010

State lawmakers consider Medicaid changes

The Houston Chronicle: "Some Republicans who talk about Texas potentially opting out of Medicaid are quick to say the changes wouldn't throw people out on the street — but not House Appropriations Committee Chairman Jim Pitts." Pitts didn't advocate the Medicaid change but "gave a stark answer when an audience member asked about an ill friend who is on Medicaid."

29 Nov 2010

China Pediatric Pharmaceuticals third quarter net sales increase 72% to $7,182,906

China Pediatric Pharmaceuticals, Inc., today announced its financial results for the third quarter ended September 30, 2010. The Company's quarterly report on Form 10-Q was filed with the U.S. Securities Exchange Commission on November 22, 2010.

29 Nov 2010

MEDRAD launches VirtualCARE solution for Intego PET Infusion System

MEDRAD, Inc. a business of Bayer HealthCare, today announces the U.S. launch of VirtualCARE®, for the MEDRAD Intego™ PET Infusion System. VirtualCARE is a technology platform that allows MEDRAD to remotely support maintenance and system updates securely over the internet.

29 Nov 2010

ACO's raise hope but also questions

The Wall Street Journal: "Spurred by incentives in the federal health-overhaul law, hospitals and doctors around the country are beginning to create new entities that aim to provide more efficient health care," called ACO's. "But these efforts are already raising questions about whether they can truly save money, or if they might actually drive costs higher. In Arizona, Tucson Medical Center is forming a company that the hospital will own jointly with local physicians' practices.

29 Nov 2010

DK Sinopharma third quarter sales increase 66% to $7,290,685

DK Sinopharma, Inc., announced its third quarter 2010 financial results. The Company's quarterly report on Form 10-Q was filed with the U.S. Securities & Exchange Commission on November 22, 2010.

29 Nov 2010

Synthon receives FDA final approval for generic Xyzal

Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.

29 Nov 2010

Wolters Kluwer Health subsidiary to acquire Pharmacy OneSource

Wolters Kluwer Health today announced that one of its wholly- owned subsidiaries has entered into an agreement to acquire Pharmacy OneSource, a leading healthcare Software-as-a-Service (SaaS) provider that helps hospitals manage the complex challenges of patient safety, compliance and efficiency. The transaction will allow Wolters Kluwer Health to extend its Clinical Decision Support (CDS) solutions into the hospital pharmacy market and will further strengthen the company's leadership position in the growing point-of-care market.

29 Nov 2010

KHN column: Replace the tattered Medicaid long-term care safety net

In his latest Kaiser Health News column, Howard Gleckman writes: "Medicaid, the state-federal health program that also pays for nearly half of all long-term care services for the frail elderly and younger people with disabilities, is in big trouble" (11/29).

29 Nov 2010

FDA approves Merit's phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere Microspheres

The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.

29 Nov 2010

Political cartoon: 'Attack Dog or Lapdog?'

Kaiser Health News provides a fresh take on health policy developments with "Attack Dog Or Lapdog?" by Monte Wolverton.

29 Nov 2010

IMRISneuro sold to Dartmouth-Hitchcock Medical Center

IMRIS Inc. today announced the sale of IMRISneuro to Dartmouth-Hitchcock Medical Center ("DHMC") in Lebanon, New Hampshire.

29 Nov 2010

DR Systems ranked leading PACS vendor for large hospitals

DR Systems, one of the most respected names in healthcare information systems, has been recognized by KLAS as the leading PACS vendor for large hospitals.

29 Nov 2010

Merck announces initial results from ISENTRESS Phase III study in HIV-1

Merck today reported initial results from the Phase III study investigating the efficacy and safety of a treatment regimen including ISENTRESS® (raltegravir) Tablets once daily in treatment-naïve adult patients infected with HIV-1. ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve and treatment-experienced adults.

29 Nov 2010

Weikang anticipates $71 - $82 million revenue for fiscal 2011

Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that for fiscal 2011, the Company expects revenue to be in the range of $71 to $82 million, net profit to be $27 to $31 million and earnings per share to be $0.97 to $1.12, based upon 28 million shares outstanding.

29 Nov 2010